92 related articles for article (PubMed ID: 376135)
1. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Miller AB; Pearson JG
Cancer Treat Rep; 1979 Feb; 63(2):289-95. PubMed ID: 376135
[No Abstract] [Full Text] [Related]
2. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
[TBL] [Abstract][Full Text] [Related]
3. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
[No Abstract] [Full Text] [Related]
4. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Young RC; Chabner BA; Hubbard SP; Fisher RI; Bender RA; Anderson T; Simon RM; Canellos GP; DeVita VT
N Engl J Med; 1978 Dec; 299(23):1261-6. PubMed ID: 101843
[TBL] [Abstract][Full Text] [Related]
5. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
Chylak V; Ilijas M; Krusić J; Kolarić K
Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
[No Abstract] [Full Text] [Related]
6. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT
Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777
[TBL] [Abstract][Full Text] [Related]
8. Histologic grade in advanced ovarian cancer.
Ozols RF; Garvin AJ; Costa J; Simon RM; Young RC
Cancer Treat Rep; 1979 Feb; 63(2):255-63. PubMed ID: 109199
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy in curable breast cancer].
Seradour B; Thomas M
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124
[No Abstract] [Full Text] [Related]
10. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
Israël L; Lepage E; Breau JL; Aguilera J
Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
[TBL] [Abstract][Full Text] [Related]
11. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
De Palo GM; De Lena M; Bonadonna G
Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
[No Abstract] [Full Text] [Related]
12. Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.
Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM
Neth J Med; 1979; 22(2):38-44. PubMed ID: 107464
[No Abstract] [Full Text] [Related]
13. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
14. Treatment and immunodiagnosis of advanced ovarian adenocarcinoma: a preliminary report.
Piver MS; Barlow JJ; Bhattacharya M
Cancer Treat Rep; 1979 Feb; 63(2):265-7. PubMed ID: 376133
[TBL] [Abstract][Full Text] [Related]
15. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.
Gershenson DM; Morris M; Burke TW; Levenback C; Wolf J; Lee JJ; Thall PF; Atkinson EN; Silva EG; Wharton JT
Cancer; 1999 Dec; 86(11):2291-300. PubMed ID: 10590370
[TBL] [Abstract][Full Text] [Related]
16. [Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer].
Sasaki T; Ota K; Ibayashi J; Sakata Y; Matsuoka T; Ishikawa M; Wakui A; Ogoshi K; Akazawa S; Sakai Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2545-55. PubMed ID: 2673045
[TBL] [Abstract][Full Text] [Related]
17. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
Barlow JJ; Piver MS
Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
[TBL] [Abstract][Full Text] [Related]
18. [Intermittent cytostatic intensive therapy of solid tumors with a combination of four drugs].
Siebner H; Hackethal L
Med Welt; 1973 Feb; 24(5):166-9. PubMed ID: 4617091
[No Abstract] [Full Text] [Related]
19. Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report.
Hreshchyshyn MM
Natl Cancer Inst Monogr; 1975 Oct; 42():155-65. PubMed ID: 1234633
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.
Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM
Cancer Treat Rep; 1980; 64(2-3):323-6. PubMed ID: 6773656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]